Intravenous vitamin C is selectively toxic to cancer cells
National Institutes of Health scientists have confirmed the concepts that vitamin C is selectively toxic to cancer cells and that tumor-toxic levels of vitamin C can be attained using intravenous administration. The article, published in the September 12, 2005 issue of the Proceedings of the National Academy of Sciences concluded, “These findings give plausibility to intravenous ascorbic acid in cancer treatment.”
[ILLUSTRATION OMITTED]
Readers can read the entire article in the December 2005 issue of the Townsend Letter or online at www.townsendletter.com
COPYRIGHT 2006 The Townsend Letter Group
COPYRIGHT 2006 Gale Group
